Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients

Keyphrases

• Rheumatoid Arthritis 100%
• Rheumatoid Arthritis Patients 100%
• Underlying Disease 100%
• Gene Signature 100%
• Interferon-α (IFN-α) 75%
• Peripheral Blood Mononuclear Cells 75%
• Specific Genes 50%
• C-reactive Protein 25%
• Biological Treatment 25%
• Infliximab 25%
• Response Pattern 25%
• Biological Agents 25%
• Patient Response 25%
• Active Rheumatoid Arthritis 25%
• Specific Response 25%
• Molecular Changes 25%
• Tocilizumab 25%
• Interferon Treatment 25%
• Interferon Response 25%
• Abatacept 25%
• Pathway Activation 25%
• Numerics 25%
• Type I Interferon Signature 25%
• Reporter Assay 25%
• Microarray Assay 25%
• Type I Interferon Signaling 25%

Biochemistry, Genetics and Molecular Biology

• Gene Expression Profiling 100%
• Interferon Type I 100%
• Peripheral Blood Mononuclear Cell 75%
• Gene Signature 50%
• Interferon 50%
• C-Reactive Protein 25%
• Upregulation 25%
• Infliximab 25%
• Abatacept 25%

Immunology and Microbiology

• Inflammatory Arthritis 100%
• Gene Expression Assay 100%
• interferon 75%
• Biological Product 37%
• Peripheral Blood Mononuclear Cell 37%
• C-Reactive Protein 12%
• Upregulation 12%
• Infliximab 12%
• Tocilizumab 12%
• Abatacept 12%
• In Vitro 12%